Search research articles
Contact Us
Filters
Showing results (171-180 of 199) with videos related to
Page
of 20
Sort By:
Journal of Psychiatric Research
|
June 10, 2009
Attitude towards adherence in patients with schizophrenia at discharge
Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
April 13, 2010
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Rebecca Schennach-Wolff, Markus Jäger, Michael Obermeier, et al.
Journal of Psychiatric Research
|
August 25, 2011
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder
Rebecca Schennach-Wolff, Sebastian Meyer, Florian Seemüller, et al.
Psychiatric Services (Washington, D.C.)
|
January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophrenia
Rebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial
Rebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Journal of Clinical Psychopharmacology
|
November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study
Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
Journal of Clinical Psychopharmacology
|
May 18, 2010
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Malek Bajbouj, Angela Merkl, Thomas E Schlaepfer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 30, 2019
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial
Rebecca Schennach, Michael Riedel, Michael Obermeier, et al.
International Journal of Methods in Psychiatric Research
|
July 17, 2015
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods
Rebecca Schennach, Hans-Jürgen Möller, Michael Obermeier, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 6, 2010
Impact of actin filament stabilization on adult hippocampal and olfactory bulb neurogenesis
Golo Kronenberg, Karen Gertz, Tina Baldinger, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 199) with videos related to
Sort By:
Page
of 20
Journal of Psychiatric Research
|
June 10, 2009
Attitude towards adherence in patients with schizophrenia at discharge
Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
April 13, 2010
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Rebecca Schennach-Wolff, Markus Jäger, Michael Obermeier, et al.
Journal of Psychiatric Research
|
August 25, 2011
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder
Rebecca Schennach-Wolff, Sebastian Meyer, Florian Seemüller, et al.
Psychiatric Services (Washington, D.C.)
|
January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophrenia
Rebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial
Rebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Journal of Clinical Psychopharmacology
|
November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study
Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
Journal of Clinical Psychopharmacology
|
May 18, 2010
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Malek Bajbouj, Angela Merkl, Thomas E Schlaepfer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 30, 2019
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial
Rebecca Schennach, Michael Riedel, Michael Obermeier, et al.
International Journal of Methods in Psychiatric Research
|
July 17, 2015
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods
Rebecca Schennach, Hans-Jürgen Möller, Michael Obermeier, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 6, 2010
Impact of actin filament stabilization on adult hippocampal and olfactory bulb neurogenesis
Golo Kronenberg, Karen Gertz, Tina Baldinger, et al.
Page
of 20